ATLANTA--(BUSINESS WIRE)--OXOS Medical®, the MedTech innovator developing simple, safe, and smart X-ray solutions, today announced its MC2 Portable X-ray System has achieved FDA 510(k) clearance and is now available for sale.
The MC2 device is portable and cordless, allowing healthcare practitioners to simplify the process of taking X-rays in traditional and non-traditional spaces. MC2 will have a profound impact on imaging by giving clinics:
- Clear imaging for a confident diagnosis. In addition to static imaging capabilities, MC2’s 9” Class detector offers Dynamic Digital Radiography (DDR) – a first for a device of this size – as well as Fluoroscopy. When practitioners can quickly access accurate images, they can diagnose the patient swiftly and return them to regular activity.
- Easy-to-use features for an efficient office. Practitioners using the MC2 can take X-rays efficiently with easy training and setup, helping reduce office wait times and getting patients the care they need quicker. The device’s Viewfinder allows for quick positioning and alignment of the X-ray beam, and its Patented Positioning System assists in alignment for image capture.
-
Freedom to move the device where needed, without hassle. Most fluoroscopes and portable X-ray systems still weigh 300 pounds or more. They’re challenging to maneuver, and some physicians ultimately choose to outsource X-ray needs to imaging centers.
MC2’s lightweight, ergonomic design makes it easy to move the device to the point of need and will allow clinicians to maximize their limited space. In addition, MC2’s small scatter area and low radiation output can reduce the space and infrastructure needs required by larger systems.
"OXOS has focused on transforming the experience of X-ray services for both clinicians and patients," said Evan Ruff, Co-founder and CEO at OXOS. "By expanding access to medical imaging, the MC2 moves us closer to our mission of providing radiographic diagnostics that are accessible anytime, anywhere — enhancing the reach and impact of X-ray technology both in the United States and globally."
MC2 is the latest release from OXOS, which launched the Micro C portable X-ray device in 2021. For the last three years, this portable solution has been used by clinics and athletic departments and has also brought X-ray capabilities to previously underserved areas.
“Everything we do at OXOS is about helping providers move into a new era of imaging,” said Dr. Gregory Kolovich, Chief Medical Officer and OXOS Co-founder. “MC2 will simplify the imaging process, empowering clinicians to provide X-ray imaging using a device a fraction of the size. We can’t wait for practices to see the difference themselves.”
For more information about MC2 and OXOS, visit https://oxos.com/.
About OXOS Medical
OXOS Medical, Inc.® is expanding access to healthcare by developing ultra-portable X-ray devices for use in clinical, surgical, and remote care scenarios. The latest innovation from OXOS, the MC2, follows the Micro C. It is FDA Cleared and uniquely captures static and serial images with dynamic digital radiography and fluoroscopy. MC2 has easy ergonomics, wireless capabilities, and a low radiation profile. OXOS devices are built to improve patient care in outpatient clinics, the military and the VA, sports facilities, hospitals, imaging centers, skills labs, and more.
